|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Trade and other receivables | ||||||||||||||
| Other current assets | ||||||||||||||
| Claims receivable | ||||||||||||||
| Inventories | ||||||||||||||
| Advances and prepayments | ||||||||||||||
| Restricted cash | ||||||||||||||
| Assets held for sale | ||||||||||||||
| Fair value of derivatives | ||||||||||||||
| Total current assets | ||||||||||||||
| Non current assets | ||||||||||||||
| Advances for vessel under construction | ||||||||||||||
| Advances for vessels' acquisitions | ||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||
| Vessels, net | ||||||||||||||
| Other receivables | ||||||||||||||
| Restricted cash | ||||||||||||||
| Investments in joint ventures | ||||||||||||||
| Deferred finance charges | ||||||||||||||
| Fair value of derivatives | ||||||||||||||
| Total non current assets | ||||||||||||||
| Total assets | ||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||
| Current liabilities | ||||||||||||||
| Payable to related parties | ||||||||||||||
| Trade accounts payable | ||||||||||||||
| Accrued and other liabilities | ||||||||||||||
| Operating lease liabilities | ||||||||||||||
| Deferred income | ||||||||||||||
| Current portion of long-term debt | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Non current liabilities | ||||||||||||||
| Operating lease liabilities | ||||||||||||||
| Deferred income | ||||||||||||||
| Long-term debt | ||||||||||||||
| Total non current liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| Stockholders' equity | ||||||||||||||
| Capital stock, 5,000,000 preferred shares authorized and zero outstanding with a par value of $0.01 per share, 100,000,000 common shares authorized, 37,041,373 shares issued and outstanding at December 31, 2024 and 37,185,686 shares issued and outstanding at December 31, 2025 with a par value of $0.01 per share | ||||||||||||||
| Treasury stock, 9,201,102 at December 31, 2023 and nil at December 31, 2024 with a par value of $0.01 per share | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Retained earnings | ||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||
| Total stockholders' equity | ||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||
Loading...